Zubair Khalid

Virologist/Molecular Biologist | Veterinarian | Bioinformatician

Conventional & Molecular Virology • Vaccine Development • Computational Biology

Dr. Zubair Khalid is a veterinarian and virologist specializing in conventional and molecular virology, vaccine development, and computational biology. Dedicated to advancing animal health through innovative research and multi-omics approaches.

Dr. Zubair Khalid - Veterinarian, Virologist, and Vaccine Development Researcher specializing in Computational Biology, Multi-omics, Animal Health, and Infectious Disease Research

Category: Guides

Dna To Mrna

DNA to mRNA is the process of transcription, in which a specific segment of DNA is copied into messenger RNA by RNA polymerase. This guide explains transcription in a practical, source bounded framework for students, laboratory researchers, and bioinformatics practitioners who need to understand, analyze, or troubleshoot the conversion of genetic information from DNA to mRNA. For a fundamental reference on gene expression, see the NCBI Bookshelf resources on transcription NCBI Bookshelf.

Transcription begins when RNA polymerase binds to a promoter region on DNA, unwinds the double helix, and synthesizes a complementary RNA strand using one DNA strand as a template. The resulting pre mRNA undergoes processing: addition of a 5' cap, splicing to remove introns, and polyadenylation to form a mature mRNA that can be exported to the cytoplasm. For training in RNA biology and data handling, the EMBL EBI offers dedicated modules EMBL EBI Training.

At a Glance

Step Key Components Common Checks
Initiation Promoter, RNA polymerase, transcription factors Promoter motif identification, RNA Pol II enrichment
Elongation DNA template, NTPs, RNA polymerase Sequencing coverage uniformity, read depth per base
Termination Polyadenylation signal, termination factors 3' end mapping, polyA site usage
RNA Processing Spliceosome, cap binding complex, polyA polymerase Intron retention rate, exon junction ratios, cap presence

Core Concepts

Transcription machinery. RNA polymerase II transcribes protein coding genes in eukaryotes. It requires general transcription factors that assemble at the promoter. The TATA box and other regulatory elements determine where transcription starts. This universal mechanism is described in detail in molecular biology textbooks on NCBI Bookshelf NCBI Bookshelf.

RNA processing. The primary transcript (pre mRNA) is modified co transcriptionally. A 7 methylguanylate cap is added to the 5' end, protecting the RNA from degradation and aiding ribosome binding. Introns are excised by the spliceosome, and exons are joined. The 3' end is cleaved and polyadenylated. These steps are critical for generating a functional mRNA and are reviewed in EMBL EBI training materials EMBL EBI Training.

Alternative splicing. A single gene can produce multiple mRNA isoforms by selecting different exon combinations. This greatly expands the proteome and is a major source of regulation. Misregulation of splicing is implicated in many diseases, as seen in a study of TP53 mis splicing and RNA based therapy Splice altering TP53 missense mutations as drivers of dysfunction and targets for RNA based therapy.

Decision Points for DNA to mRNA Analysis

When studying transcription, you must decide on the level of detail and the methods that match your biological question.

  • Global versus targeted. RNA sequencing (RNA seq) captures all transcripts, while reverse transcription PCR (RT PCR) targets specific genes. Use RNA seq for discovery and quantification of entire transcriptomes. Use RT PCR for validation or when sample amount is limited. The Galaxy Training Network provides workflows for both approaches Galaxy Training Network.
  • Strand specific data. Knowing which DNA strand was transcribed is essential for assigning reads to the correct gene and for detecting antisense transcription. Choose strand specific library preparation if you need accurate isoform quantification or plan to study non coding RNAs.
  • Isoform resolution. Short read sequencing (e.g., Illumina) can quantify known isoforms but struggles to assemble novel ones. Long read sequencing (PacBio, Oxford Nanopore) captures full length transcripts but currently has higher error rates. Your choice depends on whether you need novel isoform discovery versus accurate quantification. Bioconductor packages like DEXSeq and IsoformSwitchAnalyzeR are designed for isoform level analysis Bioconductor.
  • RNA source and quality. Tissue type, cell enrichment, and RNA integrity number (RIN) strongly affect results. For degraded RNA (RIN < 6), consider using 3' tagging methods or targeted approaches.

Practical Workflow for DNA to mRNA Analysis

Step 1. Experimental Design and Sample Preparation

Identify the organism, tissue, and condition. Extract total RNA using a phenol chloroform method or column based kit. Perform a DNase treatment to remove genomic DNA contamination. Assess RNA integrity via bioanalyzer or gel electrophoresis. A RIN >= 8 is recommended for standard RNA seq.

Step 2. Library Preparation and Sequencing

Select a library kit appropriate for your goals (e.g., polyA enrichment for mRNA, ribodepletion for total RNA, or targeted panels). Include unique molecular identifiers (UMIs) if you need absolute quantification. Sequence on a platform that provides sufficient read depth (typically 20,50 million reads per sample for human transcriptome quantification). Public sequencing data are available at the NCBI Sequence Read Archive NCBI Sequence Read Archive.

Step 3. Quality Control of Raw Reads

Use tools like FastQC or MultiQC to check per base quality, GC content, adapter contamination, and duplication rates. Trim adapters and low quality bases with Cutadapt or Trimmomatic. The Galaxy Training Network provides step by step tutorials for QC in RNA seq Galaxy Training Network.

Step 4. Read Alignment

Map reads to a reference genome or transcriptome using a splice aware aligner (STAR, HISAT2). For transcriptome only alignment, use Salmon or Kallisto in quasi mapping mode. Verify alignment rates (typically > 70% for good quality data). Check for uniformity of coverage across transcripts.

Step 5. Quantification and Normalization

Count reads mapping to genes or transcripts using featureCounts or htseq count. Normalize counts using TPM (transcripts per million) or FPKM (fragments per kilobase per million) for comparing expression within a sample, or using DESeq2 or edgeR for differential expression between conditions. Bioconductor packages provide robust statistical frameworks for normalization and differential testing Bioconductor.

Step 6. Quality Checks for Quantified Data

Perform principal component analysis (PCA) to detect batch effects or outliers. Check the distribution of normalized counts (most genes should have low expression). Evaluate the correlation between technical replicates (Pearson r > 0.95). Confirm that known housekeeping genes are stable across conditions.

Step 7. Biological Interpretation

Annotate differentially expressed genes with gene ontology (GO) terms or pathway enrichment (e.g., KEGG, Reactome). Integrate with other data types such as chromatin accessibility or protein levels if available. For example, a study on chronic hepatitis B used RNA expression of MX2 and SAMD4A to predict treatment responses, linking DNA to mRNA changes to clinical outcomes Altered expression of MX2 and SAMD4A in PBMCs predicts early treatment responses in HBeAg positive chronic hepatitis B patients during Peg IFN alpha therapy.

Common Mistakes

  • Ignoring genomic DNA contamination. If DNase treatment is omitted or insufficient, reads from intronic or intergenic DNA will inflate expression estimates. Always include a no reverse transcriptase control.
  • Misinterpreting intron retention as noise. Some intron retention is biologically meaningful, especially during stress or in specific cell types. Do not automatically discard intronic reads without checking for known retained introns.
  • Using wrong strand information. Many aligners assume non strand specific data by default. If you have strand specific libraries, specify the appropriate option (e.g., --outSAMstrandField intronMotif for STAR).
  • Overlooking batch effects. Batch effects from different sequencing runs or sample processing days can swamp biological signals. Always include batch as a covariate in statistical models.
  • Over quantification of lowly expressed genes. Genes with very low counts are highly variable. Filter out genes with mean normalized count less than 5,10 before differential testing.

Limits of Interpretation

  • mRNA levels do not always predict protein abundance. Post transcriptional regulation, translation efficiency, and protein turnover can cause discordance. Direct measurement of protein (e.g., mass spectrometry) is needed for accurate proteome inference.
  • Isoform quantification is uncertain. Short reads cannot unambiguously assign reads to isoforms that share exons. Long reads improve isoform resolution but have higher error rates. Always report confidence intervals or use Bayesian methods for isoform quantification.
  • Technical variation in library preparation. PolyA selection can bias against short or non polyA transcripts. Ribodepletion may retain fragments of ribosomal RNA. Consider these biases when comparing across studies.
  • Tissue and cell type heterogeneity. Bulk RNA seq averages signals from multiple cell types. Single cell RNA seq can resolve cell type specific transcription but has lower sensitivity per cell.
  • Transcription is only one layer of gene regulation. Epigenetic modifications, chromatin accessibility, and transcription factor binding all influence transcription. For example, integrated multi omics analysis revealed that epigenetic silencing of PHYHD1 occurs in hepatocellular carcinoma, affecting its mRNA expression Epigenetic silencing of PHYHD1 in hepatocellular carcinoma revealed by integrated multi omics analysis. Similarly, mitochondrial transcription factor A deficiency in T cells alters immune signaling through mRNA changes, but the full pathway involves multiple factors Mitochondrial Transcription Factor A Deficiency in T Cells Leads to Activation of the Cyclic Guanosine Monophosphate Adenosine Monophosphate Synthase Stimulator of Interferon Genes Pathway and Production of Autoantibodies in Mice.

Frequently Asked Questions

1. What is the main difference between DNA and mRNA? DNA is a double stranded molecule that stores genetic information, while mRNA is a single stranded copy that carries the coding sequence to ribosomes for protein synthesis. DNA contains deoxyribose and thymine, mRNA contains ribose and uracil.

2. How does transcription start? Transcription starts when RNA polymerase binds to a promoter region upstream of a gene. In eukaryotes, general transcription factors help recruit RNA polymerase II and position it at the transcription start site. The promoter typically contains a TATA box or other core motifs.

3. What is alternative splicing and why is it important? Alternative splicing is the process by which a single pre mRNA can be spliced into different mature mRNAs by including or excluding certain exons. This allows one gene to produce multiple protein variants and is a major source of functional diversity. Studies on HLA alleles and TP53 splicing illustrate its clinical relevance Confirmation of the HLA B 35 642 Allele in a Brazilian Individual.

4. How can I tell if my RNA seq data are good quality? Key metrics include: high per base quality scores (Phred > 30), low adapter contamination (< 5% of reads), high alignment rate to the reference (> 70%), and a broad distribution of gene expression values. Also verify that the GC content matches the expected genome composition.

References and Further Reading

Related Articles